Elucidation of genes involved in individual differences in ondansetron sensitivity

Elucidation of gene polymorphisms that contribute to nausea and vomiting after administration of ondansetron - Elucidation of gene polymorphisms that contribute to nausea and vomiting after administration of ondansetron

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051727

Enrollment

100

Registered

2023-07-27

Start date

2023-05-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing orthognathic surgery

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligible patients meet the criteria of the American Society of Anesthesiologists(ASA) physical status of I-II.

Exclusion criteria

Exclusion criteria: Eligible patients meet the criteria of the American Society of Anesthesiologists(ASA) physical status of 3-5. Patients without consent.

Design outcomes

Primary

Measure	Time frame
Postoperative nausea attitude,Frequency of vomiting (2 hours later, 24 hours later)	—

Secondary

Measure	Time frame
Whether to use rescue anti-emetics (metoclopramide)	—

Countries

Japan

Contacts

Public ContactYuna Kang

Tokyo Dental College Dental Anesthesiology

yunakang@tdc.ac.jp03-6380-9001

Outcome results